创新药板块诞生4只“翻倍基”；中央汇金资产二季度增持多只宽基ETF丨天赐良基早参

Group 1: Leadership Changes - Xiaoyi Helen Huang has resigned as Chairman of Fidelity Fund due to personal reasons, effective July 18, with Shaojie Li appointed as the new Chairman [1] - Zhang Shunguo has been appointed as the new Chief Supervisor of Industrial Fund, effective July 18, previously serving as Vice General Manager [2] - Liu Jian has been appointed as Vice General Manager of Tongtai Fund, having previously been promoted to Assistant General Manager earlier this year [6][7] Group 2: Investment Trends - Central Huijin Asset Management has significantly increased its holdings in multiple broad-based ETFs, with total purchases exceeding 190 billion yuan in the second quarter [3] - The innovative drug sector has seen the emergence of four "doubling funds" in 2023, with the top performer, Huatai-PB Hong Kong Advantage Selection, achieving a 133.72% increase [4] - Zhang Kun's fund management has shown notable changes, including the addition of JD Health to the top ten holdings and a reduction in Tencent Holdings [5] Group 3: Market Performance - On July 21, the market experienced a strong upward trend, with both the Shanghai Composite Index and the ChiNext Index reaching new highs for the year, led by sectors such as cement, machinery, and steel [8]